Assuming studies is required, the following results were found.

  • Tecfidera (dimethyl fumarate)

    having a severe allergic reaction to this drug, call 911. Hair loss Hair loss isn't a side effect that has occurred in studies of Tecfidera. However, some people who take Tecfidera have had hair loss. In one report, a woman who started taking Tecfidera...

    https://mschristian.org/index.php/blog/tecfidera-dimethyl-fumarate
  • Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

    leader in neuroscience, today announced positive results for #ofatumumab (OMB157) from the Phase III ASCLEPIOS I and II studies. In both head-to-head studies, ofatumumab demonstrated superiority over Aubagio®* (teriflunomide) in patients with relapsing...

    https://mschristian.org/index.php/blog/novartis-ofatumumab-demonstrates-superiority-versus-aubagio-in-two-head-to-head-phase-iii-multiple-sclerosis-studies-1
  • Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

    leader in neuroscience, today announced positive results for ofatumumab (OMB157) from the Phase III ASCLEPIOS I and II studies. In both head-to-head studies, ofatumumab demonstrated superiority over Aubagio®* (teriflunomide) in patients with relapsing...

    https://mschristian.org/index.php/blog/novartis-ofatumumab-demonstrates-superiority-versus-aubagio-in-two-head-to-head-phase-iii-multiple-sclerosis-studies
  • Fooling nerve cells into acting normal

    Discovery could inform future studies related to spinal cord injuries, multiple sclerosis and epilepsy Date:Source:University of Missouri-ColumbiaSummary:Scientists have discovered that a neuron's own electrical signal, or voltage, can indicate whether...

    https://mschristian.org/index.php/blog/fooling-nerve-cells-into-acting-normal
  • Research on immune activity in MS

    to axons (the wire-like nerve fibers) that contributes to longer-term disability. Research on the immune system includes studies on:Understanding components of the immune system such as T cells, B cells, and antibodiesIdentifying new targets for...

    https://mschristian.org/index.php/blog/research-on-immune-activity-in-ms
  • Aubagio (teriflunomide)

    didn't worsen as quickly) a lower risk for new lesions (scar tissue) in the brain For specific information from these studies, see the "Aubagio uses" section. Aubagio generic Aubagio is currently available only as a brand-name medication. Aubagio...

    https://mschristian.org/index.php/blog/aubagio-teriflunomide
  • Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

    Methods We measured NfL in blood samples from 589 patients with relapsing-remitting multiple sclerosis (from phase 3 studies of fingolimod vs placebo, FREEDOMS and interferon [IFN]-β-1a, TRANSFORMS) and 35 healthy controls and compared NfL levels with...

    https://mschristian.org/index.php/blog/blood-neurofilament-light-chain-as-a-biomarker-of-ms-disease-activity-and-treatment-response
  • Researchers find possible causes for lacking of effective therapy for multiple sclerosis

    and clinical trials. In the process, the authors link the discussion of therapy targets with results from pharmacological studies conducted with cell culture and animal models, as well as current clinical studies. One disease, numerous mechanisms A...

    https://mschristian.org/index.php/blog/researchers-find-possible-causes-for-lacking-of-effective-therapy-for-multiple-sclerosis
  • Potential genetic markers of multiple sclerosis severity

    of the brain and immune systems -- by using DNA from MS patients along with high-tech retinal scanning. If further studies confirm the researcher's findings, reported in the September issue of Brain, the investigators say they could serve as markers for...

    https://mschristian.org/index.php/blog/potential-genetic-markers-of-multiple-sclerosis-severity
  • Vitamin D no defense against dementia

    Iacopetta, PhD candidate at the University of Adelaide. Based on a systematic review of over 70 pre-clinical and clinical studies, Ms Iacopetta investigated the role of vitamin D across a wide range of neurodegenerative diseases. "Past studies had found...

    https://mschristian.org/index.php/blog/vitamin-d-no-defense-against-dementia
  • #ECTRIMS2019 – Tysabri During Pregnancy and After Delivery Seems Safe, Reduces Relapse Risk, Study Finds

    activity. Those guidelines recommend treatment be restarted within 8-12 weeks after the last dose pre-delivery. Prior studies suggested that Tysabri use over the first trimester of pregnancy is not tied to major fetal risks. However, the medicine can be...

    https://mschristian.org/index.php/blog/ectrims2019-tysabri-during-pregnancy-and-after-delivery-seems-safe-reduces-relapse-risk-study-finds
  • Do minerals play a role in development of multiple sclerosis?

    Some studies have suggested that minerals such as zinc and iron may play a role in how multiple sclerosis (MS) progresses, once people have been diagnosed with it. But little was known about whether zinc, iron and other minerals play a role in the...

    https://mschristian.org/index.php/blog/do-minerals-play-a-role-in-development-of-multiple-sclerosis
  • MS: High-strength MRI may predict disease progression

    lesions and, in this instance, it was able to detect many lesions that researchers have not been able to see in previous studies. Researchers used a powerful MRI scanner to monitor people with multiple sclerosis and found a link between the total volume...

    https://mschristian.org/index.php/blog/ms-high-strength-mri-may-predict-disease-progression-1
  • Research Project 3TR To Use Breath Biopsy, Improve Immune-mediated Disease Management - Technology Networks

    provide Breath Biopsy Collection Stations and Kits for the collection of breath samples, and analysis services for multiple studies that have been identified at this stage as suitable to include breath sampling, alongside clinical and physiological...

    https://mschristian.org/index.php/blog/research-project-3tr-to-use-breath-biopsy-improve-immune-mediated-disease-management-technology-networks
  • Genmab A/S (GMAB) Detailed Results from Phase III ASCLEPIOS I & II Studies of Ofatumumab in Patients with Relapsing MS Presented at ECTRIMS - StreetInsider.com

    to access https://www.streetinsider.com/Corporate News/Genmab AS (GMAB) Detailed Results from Phase III ASCLEPIOS I & II Studies of Ofatumumab in Patients with Relapsing MS Presented at ECTRIMS/15912802.html from 204.152.211.44 on 2019-09-15 15:49:39...

    https://mschristian.org/index.php/blog/genmab-a-s-gmab-detailed-results-from-phase-iii-asclepios-i-ii-studies-of-ofatumumab-in-patients-with-relapsing-ms-presented-at-ectrims-streetinsider-com
  • NIH trial aims to improve drug discovery for ischemic stroke

    in rodents. The NIH is calling on researchers to make the standards and practices applied in preliminary, preclinical studies (such as randomization and blinding) more similar to the ones used in clinical trials. The aim is to improve clinical trial...

    https://mschristian.org/index.php/blog/nih-trial-aims-to-improve-drug-discovery-for-ischemic-stroke
  • Multiple sclerosis: Perilous ruptures

    disrupting the ionic balance and ultimately killing the axon. The new findings appear in the journal Neuron. In previous studies, Kerschensteiner, Misgeld and colleagues had observed that axons in inflammatory lesions often were swollen and subsequently...

    https://mschristian.org/index.php/blog/multiple-sclerosis-perilous-ruptures
  • Handling Stress - Mind-Body Basics for People with MS

    serves as senior director of patient management, care, and rehabilitation research for the National MS Society. Numerous studies have shown the mind can have a big impact ona person’s physical symptoms, Zackowski explains. Stress and anxiety in...

    https://mschristian.org/index.php/blog/handling-stress-mind-body-basics-for-people-with-ms
  • Biogen Strengthens MS & SMA Portfolio as Competition Lurks - Yahoo Finance

    Alzheimer’s candidate aducanumab and more recently, elenbecestat. In September, Biogen and Eisaidiscontinued two late-stage studies on elenbecestat. The decision was taken following a safety review conducted by the Data Safety Monitoring Board. The...

    https://mschristian.org/index.php/blog/biogen-strengthens-ms-sma-portfolio-as-competition-lurks-yahoo-finance
  • Treating pediatric MS

    showed that the safety and efficacy in children were similar to that in the adult MS population. Smaller retrospective studies, case studies and unblinded controlled trials have demonstrated safety and efficacy of the self-injected MS disease modifying...

    https://mschristian.org/index.php/blog/treating-pediatric-ms

Results 1 - 20 of 95
 
 

Follow Us on Twitter

Follow Us On Twitter - Image